D-Ribose (mixture of isomers) -13C5

D-Ribose (mixture of isomers) -13C5 isomers) -13C5 is the 13C labeled D-Ribose (mixture of isomers) [1]. D-Ribose (mixture of isomers) is an energy enhancer, and acts as a sugar moiety of ATP, and widely used as a metabolic therapy supplement for chronic fatigue syndrome or cardiac energy metabolism. D-Ribose (mixture of isomers) is active in protein glycation, induces NF-κB inflammation in a RAGE-dependent manner[1].

Product Specifications

CAS Number

[202114-47-4]

UNSPSC

12352211

Hazard Statement

H302, H315, H319, H335

Target

Endogenous Metabolite

Type

Isotope-Labeled Compounds

Related Pathways

Metabolic Enzyme/Protease

Applications

Metabolism-protein/nucleotide metabolism

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/d-ribose-mixture-of-isomers-13c5.html

Purity

99.95

Solubility

H2O : 100 mg/mL (ultrasonic)

Smiles

O[13C@H]([13C@@H]([13CH2]O)O)[13C@H]([13CH]=O)O

Molecular Formula

13C5H10O5

Molecular Weight

155.09

Precautions

H302, H315, H319, H335

References & Citations

[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53 (2) :211-216.|[2]Hong J, et al. D-ribose induces nephropathy through RAGE-dependent NF-κB inflammation. Arch Pharm Res. 2018 Aug;41 (8) :838-847.